A Novel Oral Natural Extract for the Treatment of Senile Purpura
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01183910 |
Recruitment Status : Unknown
Verified June 2011 by Nexgen Dermatologics, Inc..
Recruitment status was: Active, not recruiting
First Posted : August 18, 2010
Last Update Posted : June 8, 2011
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
PURPURA | Dietary Supplement: Citrus Bioflavanoid Blend Dietary Supplement: Calcium Carbonate | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 75 participants |
Allocation: | Randomized |
Intervention Model: | Single Group Assignment |
Masking: | Double (Participant, Investigator) |
Official Title: | A Randomized, Double-Blind, Placebo-Controlled Study To Assess the Safety and Efficacy of a Novel Oral Natural Extract for the Treatment of Senile Purpura |
Study Start Date : | November 2008 |
Estimated Primary Completion Date : | July 2011 |
Estimated Study Completion Date : | August 2011 |

Arm | Intervention/treatment |
---|---|
Placebo Comparator: Calcium carbonate placebo pill
Placebo medication to treat the appearance of the skin in patients with senile purpura
|
Dietary Supplement: Calcium Carbonate
Oral Tablet Taken Twice a Day |
Active Comparator: Nutraceutical
Patients take a novel, natural nutraceutical product to improve the appearance of the skin of patients with senile purpura
|
Dietary Supplement: Citrus Bioflavanoid Blend
Pill Taken Twice a Day |
- IMPROVEMENT IN PATIENT'S SKIN APPEARANCE WITH SENILE PURPURA [ Time Frame: 6 WEEKS ]
- ADVERSE EFFECTS IN PATIENTS WITH SENILE PURPURA TAKING THIS MEDICATION [ Time Frame: 6 WEEKS ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Patients with evidence of purpura on physical exam
Exclusion Criteria:
- Preexisting condition that would not allow the patients to take oral calcium supplement

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01183910
United States, Florida | |
Berlin Center of Medical Aesthetics | |
Boynton Beach, Florida, United States, 33437 |
Principal Investigator: | JOSHUA M BERLIN, MD | STUDY PROTOCOL, INC |
Responsible Party: | GARY BERLIN, ESQUIRE, NEXGEN DERMATOLOGICS, INC. |
ClinicalTrials.gov Identifier: | NCT01183910 |
Other Study ID Numbers: |
021775 |
First Posted: | August 18, 2010 Key Record Dates |
Last Update Posted: | June 8, 2011 |
Last Verified: | June 2011 |
PURPURA SENILE PURPURA BATEMAN'S PURPURA |
Purpura Blood Coagulation Disorders Hematologic Diseases Hemorrhage Pathologic Processes Skin Manifestations Calcium Carbonate |
Calcium Calcium-Regulating Hormones and Agents Physiological Effects of Drugs Antacids Molecular Mechanisms of Pharmacological Action Gastrointestinal Agents |